Mouse WRN Helicase Domain Is Not Required for Spontaneous Homologous Recombination-Mediated DNA Deletion by Brown, Adam D. et al.
SAGE-Hindawi Access to Research
Journal of Nucleic Acids
Volume 2010, Article ID 356917, 6 pages
doi:10.4061/2010/356917
Research Article
MouseWRNHelicaseDomain Is NotRequiredforSpontaneous
HomologousRecombination-Mediated DNA Deletion
Adam D. Brown,1,2 AlisonB. Claybon,1 and Alexander J. R. Bishop1,2
1Greehey Children’s Cancer Research Institute, The University of Texas Health Science Center at San Antonio,
San Antonio, TX 78229, USA
2Department of Cellular and Structural Biology, The University of Texas Health Science Center at San Antonio,
San Antonio, TX 78229, USA
Correspondence should be addressed to Alexander J. R. Bishop, bishopa@uthscsa.edu
Received 16 May 2010; Accepted 7 July 2010
Academic Editor: Ashis Basu
Copyright © 2010 Adam D. Brown et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Werner syndrome is a rare disorder that manifests as premature aging and age-related diseases. WRN is the gene mutated in WS,
and is one of ﬁve human RecQ helicase family members. WS cells exhibit genomic instability and altered proliferation, and in
vitro studies suggest that WRN has a role in suppressing homologous recombination. However, more recent studies propose that
other RecQ helicases (including WRN) promote early events of homologous recombination. To study the role of WRN helicase on
spontaneous homologous recombination, we obtained a mouse with a deleted WRN helicase domain and combined it with the in
vivo pink-eyed unstable homologous recombination system. In this paper, we demonstrate that WRN helicase is not necessary for
suppressing homologous recombination in vivo contrary to previous reports using a similar mouse model.
1.Introduction
Werner syndrome (WS) is a rare autosomal recessive disease
associated with premature age-related phenotypes such as
cancer, osteoporosis, diabetes mellitus and early graying of
the hair (review [1]). The gene responsible for WS (WRN)i s
oneofaﬁvehumanRecQhelicasesincludingBLM,RECQL1,
RECQL4, and RECQ5. Like WS, the absence of BLM and
RECQL4 gives rise to the clinically distinct diseases, Bloom’s
syndrome (BS) and Rothmund-Thomson syndrome, respec-
tively. Although a variety of diﬀerent WRN mutations have
been discovered, many result in a truncated nonfunctional
WRN (summarized in [2]). Cells from WS patients depict an
aging phenotype including reduced proliferation associated
with an increase in S-phase [3] and early passage senescence
[3, 4]. Furthermore, WS cells show increased levels of
genomic instability thought be caused from increased levels
of illegitimate recombination. These observations lead us to
investigate the role of WRN in vivo.
For this study we used a WRN mouse model with a
deleted helicase domain [5] in combination with the well-
established murine pink-eyed unstable (pun) mouse model
that can be used to determine changes in the spontaneous
frequency of somatic homologous recombination (HR)
events [6–8]. Though rare, this particular Wrn mutation has
been found in a small population of WS patients [9, 10]a n d
is therefore relevant to the human disease. The pun assay is
based on an HR-mediated deletion of one copy of a 70kb
DNA duplication that encompasses exons 6–18 of the p
gene [11]. The exact deletion of one copy of the repeated
region will restore the function of this pigmentation gene,
and this can be observed as somatic events in pigmented
tissues such as the fur and the retinal pigment epithelium
(RPE) [8, 12]. The further development of the pun eye spot
assay which identiﬁes pun reversion events on a monolayer of
clear RPE cells has proven to be signiﬁcantly more sensitive
and informative than the fur spot assay [6].
Studiesinyeastusingasimilarduplication/deletion assay
to the pun reversion assay have identiﬁed several possible
mechanisms of HR that may mediate this type of deletion
event. These include intrachromatid exchange, one-sided
strand invasion, unequal sister chromatid exchange (SCE),
sister chromatid conversion, and single-strand annealing
(SSA) [13]. Excluding SSA, each of these HR mechanisms2 Journal of Nucleic Acids
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Figure 1: HR-mediated reversion of the pun allele. Schematic of the
pun mutation (tandem duplication of exons 6–18), where an HR
event mediates the deletion of one copy rendering a functional p
gene allowing pigmentation of RPE cells. Circles and arrowheads
represent centromere and telomere DNA, respectively.
is considered RAD51-dependent. RAD51-dependent HR is
considered a high ﬁdelity DNA repair mechanism that is
frequently associated with DNA replication (review [14]).
For example, replication forks can stall or collapse when
the replication machinery encounters DNA damage like a
single strand break, and HR is capable of repairing the
damaged DNA template and restoring the replication fork
[15]. Claybon et al. recently reported that in the absence
of PARP1, somatic HR events, measured by the pun system,
are highly elevated and that a majority of these events were
large clonally expanded cells [16]. These authors went on to
suggest that these clonally expanded populations of cells are
the result of an HR-mediated deletion that occurred during
replication, probably in a RAD51-dependent mechanism (as
compared to SSA). The utility of the helicase domain of
mouse WRN is discussed below.
2.MaterialsandMethods
2.1.MouseLinesandPCRGenotyping. WRNhelicasemutant
(WrnΔhel/+)[ 5] mice on an FVB strain background were
obtained from Dr. P. Leder, and C57BL/6J and C57BL/6J
pun/un mice were obtained from the Jackson Laboratory
(Bar Harbor, ME). In order to obtain congenic C57BL/6J
pun/unWrnΔhel/+ mice (hereafter called WrnΔhel/+), WrnΔhel/+
mice were backcrossed 5 times to C57BL/6J followed by
two additional crosses to C57BL/6J pun/un mice. All mice
were maintained with pun/un mutation. Control (Wrn+/+)
and experimental (WrnΔhel/Δhel) animals result from cross-
ing WrnΔhel/+mice together. The pun/un allele was geno-
typed by the identiﬁcation of the phenotypic dilute coat
color. Genotypes for the Wrn allele were determined by
a PCR ampliﬁcation protocol obtained from Aya Leder,
Harvard Medical School, MA consisting of the follow-
ing 3 primers: (1) 5 -GTTTCCTCTATCATCTGTAACAGG-
3 ,( 2 )5  -GCGAAGGAGCAAAGCTGCTAT-3  and (3) 5 -
AGTGAGACATGTATGACTACC-3  and the thermo proﬁle:
1c y c l eo f9 4
◦C for 5min; 30 cycles of 94
◦C for 30s, 60
◦C
for 30s, and 72
◦C for 1min; 1 cycle of 72
◦C for 3min.
Amplicon size for the wt PCR product is 350bp and Wrn
mutant 450bp. When necessary, genomic DNA was isolated
from ﬁxed RPE using the Qiagen DNeasy Blood and Tissue
kit according to manufacture’s recommendations.
2.2. Dissection, Visualizing, and Scoring Eye Spots on the Reti-
nalPigmentEpithelium. Harvestingoftheeyeanddissection
of the RPE were carried out as previously described in [7].
RPE whole mounts were visualized and imaged using a
Zeiss Lumar V.12 stereomicroscope, Zeiss Axiovision MRm
camera, and Zeiss Axiovision 4.6 software (Thornwood,
NY). pun reversion events were identiﬁed on the transparent
monolayer of the RPE as pigmented cells or eye spots. Total
number of eye spots and number of cells making up that eye
spot were recorded for each RPE according to the criteria set
forthbyBishopetal.in[7].Additionally,therelativedistance
from the optic nerve of each eye spot was recorded. This was
done by using the measurement tool in Adobe Photoshop,
by ﬁrst measuring from the center of the optic nerve to the
proximal edge of the eye spot and then from the center of the
optic nerve to the edge of the RPE. The relative distance is
then determined by dividing the former by the latter.
2.3. Statistical Analysis. All statistics were carried using
GraphPad Prism (La Jolla, CA). These include tests for nor-
mality (Shapiro-Wilk test), equal variances (Fmax test), two
group comparisons (Mann-Whitney test), and contingency
tables (Fisher’s exact test).
3. Results
3.1. Loss of WRN Helicase Activity Does Not Aﬀect the
Overall Frequency of Spontaneous Homologous Recombination
in Mouse RPE In Vivo. The frequency of spontaneous HR
for mice with helicase domain-deﬁcient WRN protein was
previously reported as being increased 2-fold using the pun
fur spot assay [17]. Though the pun fur spot assay can
be considered a faithful assay for measuring HR frequency
in vivo, the puneye spot assay aﬀords many advantages,
including being more sensitive to changes in HR frequency
[8] and can reveal information about the timing of events
during development [7], developmental patterning [18], and
eveninformationaboutwhethertheHReventsareassociated
with replication [16]. Therefore, we set out to recapitulate
the fur spot study and to determine whether we might be
able to reveal any additional phenotypes associated with the
WRNΔhel HR events. Surprisingly, when we compared the
number of eye spots per RPE in Wrn+/+ versus WrnΔhel/Δhel
(Table 1 and Figure 2(a)), we were unable to detect a signif-
icant increase in the overall frequency of HR events (P =
.35, Mann-Whitney test) (Figure 2(b)). The nonparametric
Mann Whitney test was used because our data was found
to be not normal (data not shown) with unequal variances
using a Fmax test (P<. 0001). Of interest, the variance
within the Wrn+/+ RPE was larger than expected due to
three RPEs with higher than usual numbers of reversion
events. To determine whether the lack of diﬀerence in HR
frequency between Wrn+/+and WrnΔhel/Δhel was due to the
wild-type RPE with elevated HR frequency,we compared the
frequency of eye spots of our WRN wild-type RPEs with anJournal of Nucleic Acids 3
Table 1: Summary of RPE examined and pun reversion frequency
by Wrn genotype.
Genotype Number of
RPE
Total
number of
eye spots
Avg.
number of
eye spots
per RPE
Avg. eye
spot size
(cell
number)
Wrn+/+ 53 522 10 6
Wrn
Δhel/Δhel 20 152 8 4
independent wild-type data set that was recently reported by
our laboratory [16]. No statistical diﬀerence in pun reversion
frequency was observed between these two groups of wild-
type RPE (data not shown). We therefore combined these
wild-type datasets, compared their combined pun reversion
eyespotfrequencywithWrnhel/hel, and still did not observe
any statistical diﬀerence between genotypes (Figure 2(b)).
Therefore, it appears that WRN helicase activity is not
required for HR, and no additional HR events are instigated
by the WRN mutation.
3.2. Single- and Multicell Eye Spots in Mouse RPE Are Not
Aﬀected by WRN Helicase. We classify eye spots as having
either single (1 cell) or multi-cell (≥2 cells) events [8].
Due to the edge-biased proliferation of the RPE [19]a n d
the apparent “position shift” between single-cell and multi-
cell eye spots [7], we speculate that multi-cell (clonally
expanded) pun reversion events are associated with DNA
replication (discussed below). Approximately 60% of eye
spots are normally single cell events. Even though we did not
observe an overall diﬀerence in HR frequency, we wanted to
see if WRN helicase activity aﬀected the clonal expansion of
pun reversion events. Here we found no signiﬁcant diﬀerence
between single versus multi-cell eye spots when comparing
Wrn+/+ versus WrnΔhel/Δhel RPE (P = .39, Fisher’s exact test
Figure (3)). These data indicate that the helicase activity of
WRN does not aﬀect clonal expansion of mouse RPE cells
following HR.
3.3. Distribution of HR Events during RPE Development Is
Not Aﬀected by WRN Helicase Mutation. The mouse RPE
develops radially outward from the optic nerve with an edge-
biased pattern of proliferation [19]. The RPE begins to form
in the developing eye cup at ∼8.5dpc and continues through
the ﬁrst week of postnatal development [20, 21]. Much like
the age of a tree that can be determined using its concentric
rings, the retrospective mapping of an eye spot onto an RPE
suggests when during development a pun reversion event
occurred [7]. Previously we have reported mutant genotypes
that aﬀected either the timing of pun reversion events during
RPE development or the pattern of RPE development by
examining eye spot patterns [6, 18]. In order to determine
if WRN helicase function has a role in HR at a speciﬁc point
during murine development, each RPE was divided into 10
concentricringswheretheinnermostringcontainstheoptic
nerve depicting the beginning of RPE development (0.0-0.1)
to the outer most ring at the edge of the RPE (0.9-1.0).
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Figure 2: Frequency of HR in mouse RPE. (a) Population
distribution of eye spots per RPE in wild-type (open boxes) and
Wrn
Δhel/Δhel (grey boxes). (b) Overall frequency of eye spots per RPE
shown as a box and whisker plot. No statistical diﬀerence in HR was
detected between wild-type and Wrn
Δhel/Δhel groups (P = .35).
At each interval, the pattern of positional distribution was
similar for both Wrn+/+ and WrnΔhel/Δhel for all eye spots
(P = .22, Chi-square test, Figure 4). Of note, the positional
analysis of the eye spots measures the distance from the
center of the optic nerve to the most proximal cell of an
eye spot, irrespective of the number of cells that constitutes
the eye spot. These results suggest that the eﬀect of the
WRN helicase mutation on HR does not alter the timing or
distribution of pun reversion events during mouse RPE.
4. Discussion
In summary, mice expressing a helicase-deﬁcient Wrn allele
didnothaveanincreaseinthefrequencyofspontaneousHR.
Our results diﬀer substantially from earlier work done using
this same mouse model with the less sensitive pun fur spot
assay which observed at least a 2-fold increase in pun rever-
sion events [17]. In our experience we have never observed
a discrepancy in pun reversion frequency between the neural
crest-derived melanocyte-dependent fur spot assay and the
neural epithelium-derived RPE-based eye spot assay.4 Journal of Nucleic Acids
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Figure 3: Frequency of the diﬀerent sizes of eye spot (number of
cells per eye spot) in mouse RPE. Wrn
Δhel/Δhel (grey boxes) does
not aﬀect cell size distribution compared to wild-type (open boxes)
(P = .39).
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Figure4:Positionaldistributionofalleyespots.WRNhelicasedoes
not aﬀect positional or pattern distribution (P = .22). Wild type
(open circles with dash line) and Wrn
Δhel/Δhel (closed circles with
solid line) RPE.
However, it should be noted that we have not examined
the frequency of pun fur spots in our C57BL6/J congenic
animals, and it is formally possible that the diﬀerence may
be due to diﬀerence in strain background. Our result also
diﬀers from a more recent report using the pun eye spot
assay with the expression of a transgenic dominant negative
human WRN allele [22]. This latter report observed a 30%
increase in eye spots (from an average of 6 to 8 eye spots
per RPE in wild-type and WRN impaired, resp.), a relatively
slight, though signiﬁcant increase for the pun eye spot assay,
that could be simply explained by sample size; Yamamoto
et al. [22] used approximately 50 RPE per group compared
to our 20 RPE. Alternately, the diﬀerence could be due to a
diﬀerence in using a mouse helicase deﬁcient Wrn mutant
mouse and a mouse model that expressed a transgenic
dominant negative allele of human WRN.
The pun fur spot assay is reliant upon detecting large
clonal expansions of melanocytes following pun reversion
that are visible in the fur (at least 1mm2). In contrast, the
pun eye spot assay can detect both single cell and clonally
expanded (multi-cell) reversion events. Additionally, the pun
eye spot assay can be used to determine any diﬀerences in
the timing of HR events during embryonic development. In
this study we found that the helicase activity of mouse WRN
doesnotaﬀectthefrequencyofsingleversusmulti-cellevents
and nor does it aﬀect the timing of spontaneous HR events
during mouse embryonic development.
Although WS cells are described as having genomic
instability,thereissomediscrepancyastotheroleWRNplays
inHR.InsupportofWRNasasuppressorofillegitimateHR,
WS patients exhibit variegated chromosomal translocations
[23], elevated recombination levels between microhomology
plasmids [24], approximate 2-fold increase of RAD51 focus
formation [25], and sensitivity to agents that lead to
replication stress [5, 26–28]. Additionally, WRN is known to
associatewithproteinstiedtoreplicationmachinerylikeRPA
[29–32], PCNA [33–35], Polδ [36, 37], and RAD52 [38]. In
contrast though, WS cells do not have elevated amounts of
SCE which are the hallmark of BS [39].
More recent studies have begun to show that RecQ
helicases (e.g., WRN) promote HR via mechanisms like
DNA resection. Following double-strand breaks (DSBs), the
helicase domain of Sgs1 (yeast RecQ orthologue of WRN)
is required for resection of DNA ends to produce single
strand DNA substrates for RAD51 [40, 41]. Additionally,
the helicase function of Sgs1 is required for normal kinetics
of HR at the MAT locus, and yeast mutants for Sgs1 and
Exo1 nucleaseexhibit sensitivitytoDNAdamaging atsimilar
levels to Rad52 mutants (which are diminished for HR
repair) [42] .T h e s es a m ea u t h o r ss u b s e q u e n t l yw e n to nt o
demonstrate that the RecQ helicase BLM also has some DNA
resection functions following Camptothecin-induced DSBs
andthatBLMfunctionofDSBresectionisinparallelwithan
EXO1-dependentpathway[42].Aseparatestudyinvestigated
the role of WRN following exposure to chromium(VI), an
agent known to induce DSBs, and found that chromium(VI)
treated human cells depleted of WRN and WS cells had
delayed or absent RAD51 focus formation [43]. This study
again suggests that WRN is important for promoting HR,
potentially in early steps of this process (e.g., initiation via
resection) following DNA damage. Unlike the other human
RecQ helicase members, WRN also has exonuclease activity,
so understanding which enzymatic function of WRN is
involved in promoting HR is valuable to our knowledge of
this protein, as well as insightful to the syndrome. As it
pertains to this study, we found that the helicase function of
WRN is neither necessary for, nor suppresses spontaneous
HR. With regard to other RecQ helicases, we recently found
HR to be signiﬁcantly elevated in the absence of BLM using
the pun eyespotassay(datanotshown).Considering thelack
of eﬀect observed in our study, and only a mild suppressive
eﬀect in the Yamamoto et al. study [21]c o m p a r e dt o
a deﬁciency in BLM (data not shown), it would appear
that WRN only plays a minor role in suppressing HR,
possiblytheresultofredundancyamongstthediﬀerentRecQ
family members. Together, these studies give insight into the
potential diﬀerences between two of the known ﬁve human
RecQ helicases and suggest that future studies are warranted
to better understanding the functions of WRN (and BLM) in
HR.Journal of Nucleic Acids 5
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